secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001641489-23-000043
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics receives Nasdaq delisting notice; appeals, hearing set for Aug 17, 2023
--------------------------------------------------------------------------------

- Received delisting notice on June 21, 2023 for failure to regain compliance with minimum bid price rule.
- Nasdaq to suspend trading June 30, 2023 unless appeal filed; company appealed on June 22, staying suspension.
- Hearing before Nasdaq Hearings Panel scheduled for August 17, 2023; company to submit compliance plan.
- No assurance of regaining compliance; expedited review questionnaire also submitted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000043/0001641489-23-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000043/vtvt-20230621.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer